UBS Group
AEHAU

UBS Group’s Aesther Healthcare Acquisition Corp Units AEHAU Stock Holding History

UBS Group’s Portfolio AEHAU Stock Details AEHAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-698
Closed -$7.32K – 11408
2022
Q4 		$7.32K Hold
698
– – ﹤0.01% 8909
2022
Q3 		$7K Hold
698
– – ﹤0.01% 8962
2022
Q2 		$7K Hold
698
– – ﹤0.01% 8597
2022
Q1 		$7K Hold
698
– – ﹤0.01% 8907
2021
Q4 		$7K Buy
+698
New +$7.11K ﹤0.01% 9210

UBS Group's AEHAU Position: Q1 2023 in Review

UBS Group sold out of Aesther Healthcare Acquisition Corp Units (AEHAU) in Q1 2023, closing a stake of 698 shares — an estimated $7.32K sold.

UBS Group first reported a position in AEHAU in Q4 2021 and held it in 5 quarters. The position peaked at $7.32K in Q4 2022. 0 funds tracked by Wall St. Rank hold AEHAU as of Q1 2023.

  • UBS Group reported no remaining Aesther Healthcare Acquisition Corp Units position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 698 Aesther Healthcare Acquisition Corp Units shares in Q1 2023, an estimated $7.32K.
  • UBS Group first reported a position in Aesther Healthcare Acquisition Corp Units in Q4 2021 and held it in 5 quarters.
  • UBS Group's Aesther Healthcare Acquisition Corp Units position peaked at $7.32K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Aesther Healthcare Acquisition Corp Units as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.